SCHEMBL6760701

SCHEMBL6760701

CCCOCc1ccc(O)c(C(CC(N)(C(C)C)C(C)C)c2ccccc2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.35
CHRM3 P20309 5/20 0.35
MAPT P10636 4/20 0.35
ESR1 P03372 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
KCNE1 P15382 1/20 0.35
PTGS1 P23219 1/20 0.35
HRH2 P25021 1/20 0.35
HTR2A P28223 1/20 0.35
SLC6A4 P31645 1/20 0.35
ADRA1A P35348 1/20 0.35
HRH1 P35367 1/20 0.35
OPRK1 P41145 1/20 0.35
KCNQ1 P51787 1/20 0.35
KCNH2 Q12809 1/20 0.35
CACNA1C Q13936 1/20 0.35
SCN5A Q14524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1354181 0.82 LMNA (0.40) LMNACHRM3MAPTESR1CHRM2
SCHEMBL8096707 0.81 LMNA (0.37) LMNACHRM3MAPTESR1CHRM2
SCHEMBL8109866 0.80 ERCC1 (0.39) LMNACHRM3MAPTESR1CHRM2
SCHEMBL2166388 0.78 CHRM3 (0.62) LMNACHRM3MAPTESR1CHRM2
Hydrochloric Acid SCHEMBL8096376 0.77 IGF1R (0.37) LMNACHRM3MAPTESR1CHRM2
SCHEMBL580445 0.77 MAPT (0.56) LMNACHRM3MAPTESR1CHRM2
Bromide SCHEMBL5670305 0.76 MAPT (0.55) LMNACHRM3MAPTESR1CHRM2
Hydrochloric Acid SCHEMBL8104115 0.76 DPP4 (0.40) LMNACHRM3MAPTESR1CHRM2
Mandelic Acid SCHEMBL8096709 0.75 LMNA (0.39) LMNACHRM3MAPTESR1CHRM2
SCHEMBL5683062 0.74 IDO1 (0.40) LMNACHRM3MAPTESR1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040186061-A1 Novel derivatives of 3,3-diphenylpropylamines SCHWARZ PHARMA AG 2004-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186061-A1 Novel derivatives of 3,3-diphenylpropylamines ADRB3, ADRA1D, TNNC1 LMNA 3143/4885CHRM3 70/4885MAPT 1725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.